VOLUME 63   2002   NUMBER 1

CME Pretest 3

CME Posttest 86

Editorial

4 Gratitude. Alan J. Gelenberg
[PDF]

Brainstorms

7 The Psychopharmacology of Energy and Fatigue. Stephen M. Stahl
[PDF]

Original Articles

9 Ethnicity and Treatment Response in Schizophrenia: A Comparison of 3 Ethnic Groups. Robin A. Emsley, Mimi C. Roberts, Solomon Rataemane, Janus Pretorius, Piet P. Oosthuizen, Jadri Turner, Dana J. H. Niehaus, Natasha Keyter, and Dan J. Stein
[Abstract] [PDF]

15 Open-Label Topiramate as Primary or Adjunctive Therapy in Chronic Civilian Posttraumatic Stress Disorder: A Preliminary Report. Jeffrey Berlant and Daniel P. van Kammen
[Abstract] [PDF]

21 Obsessive-Compulsive Hoarding: Symptom Severity and Response to Multimodal Treatment. [CME] Sanjaya Saxena, Karron M. Maidment, Tanya Vapnik, Gina Golden, Tanya Rishwain, Richard M. Rosen, Gerald Tarlow, and Alexander Bystritsky
[Abstract] [PDF]

28 An Open-Label Trial of Sibutramine in Obese Patients With Binge-Eating Disorder. Jose C. Appolinario, Amelio Godoy-Matos, Leonardo F. Fontenelle, Lucia Carraro, Monica Cabral, Andrea Vieira, and Walmir Coutinho
[Abstract] [PDF]

31 Reboxetine, a Selective Norepinephrine Reuptake Inhibitor, Is an Effective and Well-Tolerated Treatment for Panic Disorder. Marcio Versiani, Giovanni Cassano, Giulio Perugi, Alessandra Benedetti, Luigia Mastalli, Antonio Nardi, and Mario Savino
[Abstract] [PDF]

38 Comparative Efficacy of SSRIs and Amisulpride in Burning Mouth Syndrome: A Single-Blind Study. Giuseppe Maina, Alberto Vitalucci, Sergio Gandolfo, and Filippo Bogetto
[Abstract] [PDF]

44 An Open-Label Study of Citalopram in the Treatment of Pathological Gambling. Mark Zimmerman, Robert B. Breen, and Michael A. Posternak
[Abstract] [PDF]

49 Attitudes Toward Antipsychotics Among Outpatient Clinic Attendees With Schizophrenia. [CME] Alex Hofer, Georg Kemmler, Ursula Eder, Michaela Honeder, Martina Hummer, and W. Wolfgang Fleischhacker
[Abstract] [PDF]

54 Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study. Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, Hagit Cohen, Uri Loewenthal, and Moshe Kotler
[Abstract] [PDF]

59 Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks of Sertraline Treatment. Mark H. Rapaport, Jean Endicott, and Cathryn M. Clary
[Abstract] [PDF]

66 A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder. Michael R. Liebowitz, Murray B. Stein, Manuel Tancer, David Carpenter, Rosemary Oakes, and Cornelius D. Pitts
[Abstract] [PDF]

Letters To the Editor

75 Valproate-Induced Parkinsonism in a Demented Elderly Patient. Masaaki Iijima
[PDF]

75 Hyperinsulinemia in Psychiatric Patients Treated With Olanzapine. Tony A. Cohn, Gary Remington, and Homa Kameh
[PDF]

76 No Complications With Risperidone Treatment Before and Throughout Pregnancy and During the Nursing Period. T. Ratnayake and Susan E. Libretto
[PDF]

77 The Clinical Features of Bipolar Depression. Franco Benazzi • Reply by Philip B. Mitchell
[PDF]

78 Hemodialysis in the Treatment of Valproic Acid Overdose. Phillip Kroll and Cheta Nand
[PDF]

Book Reviews 80

NOW@Psychiatrist.com 88

Information for authors

see January 2002, page 83 or our Web site at www.psychiatrist.com/author.htm